Last reviewed · How we verify
Intrathecal morphine
At a glance
| Generic name | Intrathecal morphine |
|---|---|
| Also known as | Spinal Morphine, ITM, Morphine, Duramorph, Kadian |
| Sponsor | University of Ioannina |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Analgesic Effects of Intrathecal Morphine and Transversalis Plane Block After Cesarean Delivery
- Comparison of Intrathecal Morphine and Rectus Sheath Block for Postoperative Pain Management After Lower Abdominal Surgery With Midline Incision (NA)
- Analgesic Techniques for Robotic Prostatectomy Procedures (NA)
- Intrathecal Morphine vs Transversalis Fascia Plane Block After Cesarean Delivery
- Quality of Postoperative Analgesia and Functional Recovery After Elective Cesarean Delivery (NA)
- Intrathecal Hydromorphone vs Intrathecal Morphine to Treat Post Cesarean Pain in Patients With Opioid Use Disorder Taking Buprenorphine (PHASE4)
- Pericapsular Nerve Group Block Versus Intrathecal Morphine for Analgesia After Total Hip Arthroplasty (NA)
- Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intrathecal morphine CI brief — competitive landscape report
- Intrathecal morphine updates RSS · CI watch RSS
- University of Ioannina portfolio CI